Aurangzeb Siddique
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Aurangzeb Siddique has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Chetan Varma
Department of Cardiology, City Hospital, Birmingham, UK
1 shared publication - Eduard Shantsila
Department of Primary Care and Mental Health, University of Liverpool
1 shared publication - Gregory Yoke Hong Lip
Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool L69 3BX, UK
1 shared publication
Latest Publications
- Open Access
- 1 January 2010
- Published by Publiverse Online SRL in Journal of Angiogenesis Research
- Vol. 2 (1) , 6
Endothelial progenitor cells: what use for the cardiologist?
Endothelial Progenitor Cells (EPC) were first described in 1997 and have since been the subject of numerous investigative studies exploring the potential of these cells in the process of cardiovascular damage and repair. Whilst their exact definition and mechanism of action remains unclear, they are directly influenced by different cardiovascular risk factors and have a definite role to play in defining cardiovascular risk. Furthermore, EPCs may have important therapeutic implications and further understanding of their pathophysiology has enabled us to explore new possibilities in the management of cardiovascular disease. This review article aims to provide an overview of the vast literature on EPCs in relation to clinical cardiology.
- 1 January 2010
- Published by Publiverse Online SRL in Journal of Angiogenesis Research
- Vol. 2 (1) , 6
Open AccessEndothelial progenitor cells: what use for the cardiologist?
Endothelial Progenitor Cells (EPC) were first described in 1997 and have since been the subject of numerous investigative studies exploring the potential of these cells in the process of cardiovascular damage and repair. Whilst their exact definition and mechanism of action remains unclear, they are directly influenced by different cardiovascular risk factors and have a definite role to play in defining cardiovascular risk. Furthermore, EPCs may have important therapeutic implications and further understanding of their pathophysiology has enabled us to explore new possibilities in the management of cardiovascular disease. This review article aims to provide an overview of the vast literature on EPCs in relation to clinical cardiology.